Dx dialogues: transcellular and paracellular transport inhibitors for CKD and hyperphosphatemia
Nephrologist Sean Hashmi, MD, discusses transport inhibitors - the "newer kids on the block" - in the treatment of CKD and hyperphosphatemia.
Up Next
Dx dialogues: exciting upcoming developments in the treatment of CKD
Dx dialogues: 4 considerations in identifying patients for novel therapies for CKD
Managing CKD with chronic kidney disease
Dx dialogues: new treatment advances & future treatments for COPD
The importance of sleep while living with chronic kidney disease
Dx dialogues: cell replacement therapies for type 1 diabetes
Dx dialogues: recent advances in urinary track infection treatment
Dx dialogues: emerging therapies for MASH
Dx dialogues: pharmacologic advances for the treatment and management of schizophrenia
Dx dialogues: common and emerging treatments for CRSWNP
